NCT06855342

Brief Summary

This is a prospectively recruiting, database development study collecting images and videos of the spontaneous venous pulsation at the back of people's eyes - this is a pulse one can see on examination of the back of the eye, originating from the blood vessels around the nerve that connects the eye to the brain (the optic nerve), and is present in most people who have normal pressure around the brain. However, in people with raised pressure in the brain, this pulse disappears as the pressure rises. Many things can cause the pressure around the brain to increase, including tumours, swellings and trauma. The investigators want to test if high-quality images and videos of this pulse, taken using both hand-held and larger, fixed-platform machines, can be used to train a software tool to automatically detect this pulse. The investigators want to collect these images and videos in 2 groups of patients: those with no known or suspected brain pressure problems, and those who are suspected to have raised pressure and/or are due to undergo measurement of the pressure around the brain, called lumbar punctures or intracranial pressure bolt monitoring. These tests to check the pressure around the brain are invasive - they involve inserting needles in the back or directly into the brain to measure the pressure, and carry risks. The value of these two groups of people will be to help train the software to reasonably say whether a pulse is present or absent and, hopefully, estimate what the pressure around the brain may be without the need for an invasive test.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 15, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

August 3, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

January 15, 2025

Last Update Submit

August 1, 2025

Conditions

Keywords

Spontaneous Venous PulsationsOptic disc videography

Outcome Measures

Primary Outcomes (1)

  • • To acquire a multimodal dataset of clinical data, OCT scans and high-quality SVP fundal images and videos, to help the development of automated tools to detect and quantify SVPs.

    To acquire a multimodal dataset of clinical data, OCT scans and high-quality SVP fundal images and videos, to help the development of automated tools to detect and quantify SVPs.

    From enrollment to last study visit (optional 3 additional visits within 12 months)

Secondary Outcomes (3)

  • • To determine participant recruitment rate within the time frame of recruitment

    From study activation to end of study recruitment period, expected to be 12 months

  • To determine the screen failure rate within the timeframe of recruitment

    From study activation to end of study recruitment period, expected to be 12 months

  • To determine the study withdrawal rate

    From study activation to end of study recruitment period, expected to be 12 months

Study Arms (3)

Healthy control participants

Healthy control participants

Suspected raised intracranial pressure - due to undergo lumbar puncture

Suspected raised intracranial pressure - due to undergo lumbar puncture

Suspected raised intracranial pressure - due to undergo intracranial pressure monitoring

Suspected raised intracranial pressure - due to undergo intracranial pressure monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy controls compared to participants due to undergo lumbar puncture or intracranial pressure bolt monitoring

You may qualify if:

  • Aged ≥18 years
  • Presumed normal ICP undergoing routine mydriatic ophthalmology OCT scans.

You may not qualify if:

  • Significant media opacity restricting acquisition of retinal vein imaging and video capture in both eyes.
  • Current or previous evidence of glaucoma, glaucoma suspect, family history of glaucoma in a 1st degree relative, or non-glaucoma related optic neuropathy in both eyes.
  • Retinal vein or artery occlusions in both eyes (branch or central).
  • Active or history of proliferative diabetic retinopathy, or diabetic papillitis in both eyes.
  • Symptoms and/or signs that, in the opinion of the investigator, indicate possible raised intracranial pressure.
  • Current or previous history of disorders affecting intracranial pressure including, but not limited to, idiopathic intracranial hypertension, hydrocephalus, epilepsy, intracranial bleeds, space occupying lesions or tumours, traumatic brain injury, central nervous system inflammatory or infectious disorders, congenital neuro-cranial disorders, neurosurgical or interventional procedures. Radiologically-confirmed ischaemic stroke is permissible, provided the patient did not develop a subsequent haemorrhagic stroke or require neurosurgical intervention.
  • Current or recent (6 months) history of medication use affecting intracranial pressure including steroids, vitamin A analogues, tetracyclines, recombinant growth hormone, lithium, nitrofurantoin, nalidixic acid, sulfenazone, cyclosporine, amiodarone.
  • Bed-bound patients.
  • Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol.
  • Patients due to undergo lumbar puncture or intracranial pressure bolt monitoring:
  • Aged ≥18 years.
  • Patients due to undergo lumbar puncture with measurement of Opening and Closing CSF pressures
  • Patients due to undergo continuous ICP monitoring
  • \. Current or previous evidence of glaucoma or glaucoma suspect in both eyes.
  • \. Retinal vein or artery occlusions in both eyes (branch or central).
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's Ophthalmology Research Unit

London, London, SE5 9RS, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pseudotumor CerebriIntracranial Hypertension

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

King's Ophthalmology Research Unit

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2025

First Posted

March 3, 2025

Study Start

January 10, 2025

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

August 3, 2025

Record last verified: 2025-01

Locations